New liquid painkiller combo for kids enters first human tests
NCT ID NCT07632274
First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This early-stage study will test a liquid medicine that combines two common pain relievers—ibuprofen and acetaminophen—in children aged 6 to 11. The goal is to measure how the body absorbs and processes the drugs, not to treat pain directly. Only 12 children who have recently had pain or a dental procedure will take a single dose, and researchers will track drug levels in their blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ibuprofen and acetaminophen liquid suspension
What this could lead to
If successful, this could provide dosing information needed to offer a convenient liquid combination pain reliever for children.
What could go wrong
This is a very early, small study (12 children) focused on drug levels, not on how well it works or safety. It may not lead to a new product.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CenExel Salt Lake
RECRUITINGSalt Lake City, Utah, 84107, United States
Contact